Coronavac
Coronavac Rist ein SARS-CoV-2-Impfstoff
| Freie Übersichtsartikel | [1][2][3] |
| Wichtige Übersichtsartikel | |
| Medline Suchterm/ Synonyme | |
| Was ist das |  |
| Struktur | |
| Physiologie | |
| Knockout | |
| Transgen | |
| Mutation | |
| Polymorphismus | |
| Genexpression | |
| Inhibitoren | |
| Agonisten |
Andere Lexika[edit | edit source]
Bibliographie[edit | edit source]
- ↑ Zhang Y, Zeng G, Pan H, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021;21(2):181-192. doi:10.1016/S1473-3099(20)30843-4
- ↑ Drugs and Lactation Database (LactMed) [Internet. Bethesda (MD): National Library of Medicine (US); 2006-. COVID-19 vaccines. [Updated 2021 Oct 18].] Available from: https://www.ncbi.nlm.nih.gov/books/NBK565969/
- ↑ Silva VO, Yamashiro R, Ahagon CM, de Campos IB, de Oliveira IP, de Oliveira EL, López-Lopes GIS, Matsuda EM, Castejon MJ, de Macedo Brígido LF. Inhibition of receptor-binding domain-ACE2 interaction after two doses of Sinovac's CoronaVac or AstraZeneca/Oxford's AZD1222 SARS-CoV-2 vaccines. J Med Virol. 2021 Oct 14. doi: 10.1002/jmv.27396. Epub ahead of print. PMID: 34647623.